$2,396.00 – $4,800.00
The World Market for Personalized Medicine Tests for Cancer
This report, Personalized Medicine Tests for Cancer, provides an authoritative look at the market for companion and personalized medicine testing for cancer. The report includes a market size and forecast for personalized medicine testing by geography (US, EU, ROW). Company profiles are included and products are identified by status (on the market, in development)
Chapter One: Executive Summary
The Scourge of Cancer
Definitions of Companion Diagnostics and Cancer Diagnostics
Types of Tests Included
Marketing Personalized Medicine-Based Cancer Tests
Market
Point of View
Chapter Two: Introduction
Cancer Treatments
Cancer Risk Assessment
Cancer Screening
Cancer Monitoring
Prognosis Assessment
Technologies Used
Immunoassays:
Immunohistochemistry (IHC):
Flow Cytometry:
In Situ Hybridization:
Nucleic Acid Amplification Technologies:
Analysis of Gene Expression Patterns (Gene Signatures):
Microarrays:
Sequencing Technologies:
Mass Spectrometry:
Liquid Biopsies:
Information Technology:
Test Targets
HER2 Overexspression
EGFR
KRAS Mutations
BRAF Mutations
UGT1A1 Genetic Variants
5-Flurouracil Therapy
PIK3CA Mutations
KIF6 Mutations
ALK Mutations
Chapter Three: Market Analysis
Products on the Market
Market Analysis
Drivers
Diagnostic Companies and Pharmaceutical Companies
Growth by Geography
Chapter Four: Company Profiles.
20/20 GeneSystems, Inc.
Company Overview
Products
Abbott Laboratories
Company Overview
Products
ACT Genomics Co., Ltd.
Products
Adaptive Biotechnologies Corporation
Company Overview
Products
Admera Health (A GENEWIZ Company)
Company Overview
Agena Bioscience Inc.
Company Overview
Products
Agendia NV
Company Overview
Amoy Diagnostics Co., Ltd.
Company Overview
Products
ARKRAY, Inc.
Company Overview
Products
Biocartis
Company Overview
Products
Pharmaceutical Company Agreements
bioMérieux SA
Company Overview
Products
Cepheid (Danaher)
Company Overview
Products
Genomic Health, Inc.
Company Overview
Products
Genoptix (A Novartis Company)
Company Overview
Luminex Corporation
Company Overview
Products
Myriad Genetics, Inc.
Company Overview
Products
Qiagen N.V.
Company Overview
Products
QuanDx Inc.
Company Overview
Quest Diagnostics
Company Overview
Products
Qvella Corporation
RiboMed Biotechnologies, Inc.
Company Overview
Products
Roche
Company Overview
Products
Siemens Healthcare
Company Overview
Products
Symbiodx
Company Overview
Products
Theranostics Health Inc. (Acquired by Avant Diagnostics, Inc.)
Overview
Products
Thermo Fisher Scientific, Inc.
Company Overview
Products
LIST OF EXHIBITS
Figure 1-1: Cancer Cases by Type
Figure 1-2: Tests by Biomarker Type
Figure 1-3 Tests by Status
Figure 1-4 Market for Personalized Medicine Cancer Tests
Table 2-1 Cancer Biomarkers
Table 3-1 Personalized Medicine Cancer Tests on the Market
Table 3-2 The Market for Personalized Cancer Tests by Geographic Region
Figure 3-3 The Market for Personalized Cancer Tests by Geographic Region
